197 related articles for article (PubMed ID: 33080187)
1. Glutathione S-transferases P1-mediated interleukin-6 in tumor-associated macrophages augments drug-resistance in MCF-7 breast cancer.
Dong X; Sun R; Wang J; Yu S; Cui J; Guo Z; Pan X; Sun J; Yang J; Pan LL
Biochem Pharmacol; 2020 Dec; 182():114289. PubMed ID: 33080187
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferases P1 protects breast cancer cell from adriamycin-induced cell death through promoting autophagy.
Dong X; Yang Y; Zhou Y; Bi X; Zhao N; Zhang Z; Li L; Hang Q; Zhang R; Chen D; Cao P; Yin Z; Luo L
Cell Death Differ; 2019 Oct; 26(10):2086-2099. PubMed ID: 30683915
[TBL] [Abstract][Full Text] [Related]
3. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.
Yang SJ; Wang DD; Li J; Xu HZ; Shen HY; Chen X; Zhou SY; Zhong SL; Zhao JH; Tang JH
Gene; 2017 Aug; 623():5-14. PubMed ID: 28438694
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
Romero A; Martín M; Oliva B; de la Torre J; Furio V; de la Hoya M; García-Sáenz JA; Moreno A; Román JM; Diaz-Rubio E; Caldés T
Ann Oncol; 2012 Jul; 23(7):1750-6. PubMed ID: 22052985
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
7. DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo.
Zhang P; Zheng BB; Wang HY; Chen JH; Liu XY; Guo XL
J Pharm Pharmacol; 2014 Mar; 66(3):398-407. PubMed ID: 24533823
[TBL] [Abstract][Full Text] [Related]
8. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
9. Effect of pyruvate kinase M2-regulating aerobic glycolysis on chemotherapy resistance of estrogen receptor-positive breast cancer.
Qian Y; Bi L; Yang Y; Wang D
Anticancer Drugs; 2018 Aug; 29(7):616-627. PubMed ID: 29782350
[TBL] [Abstract][Full Text] [Related]
10. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
11. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
[TBL] [Abstract][Full Text] [Related]
12. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
[TBL] [Abstract][Full Text] [Related]
14. High Expression of SIRT1 Associates with the Doxorubicin Resistance of Breast Cancer through the Activation of Akt.
Jin X; Wei Y; Liu Y; Chen Y; Zhao B; Huang J; Yu H; Li C
Anticancer Agents Med Chem; 2020; 20(1):94-102. PubMed ID: 31746308
[TBL] [Abstract][Full Text] [Related]
15. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of the human glutathione S-transferase P1 by epidermal growth factor receptor.
Okamura T; Singh S; Buolamwini J; Haystead T; Friedman H; Bigner D; Ali-Osman F
J Biol Chem; 2009 Jun; 284(25):16979-16989. PubMed ID: 19254954
[TBL] [Abstract][Full Text] [Related]
17. Effects of geranyl-phloroacetophenone on the induction of apoptosis and chemosensitization of adriamycin-resistant MCF-7 human breast cancer cells.
Cho MY; Park SY; Park S; Lee YR; Kwak MK; Kim JA
Arch Pharm Res; 2012 May; 35(5):911-9. PubMed ID: 22644859
[TBL] [Abstract][Full Text] [Related]
18. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
Huang Q; Wu YY; Xing SJ; Yu ZW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5285-5292. PubMed ID: 31298380
[TBL] [Abstract][Full Text] [Related]
19. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
Chang L; Hu Z; Zhou Z; Zhang H
Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
[TBL] [Abstract][Full Text] [Related]
20. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]